Bahl & Gaynor’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $778K | Sell |
|
|||||
|
2025
Q1 | $1.07M | Sell |
|
|||||
|
2024
Q4 | $1.27M | Sell |
|
|||||
|
2024
Q3 | $1.92M | Sell |
|
|||||
|
2024
Q2 | $1.95M | Sell |
|
|||||
|
2024
Q1 | $2.08M | Sell |
|
|||||
|
2023
Q4 | $2.36M | Sell |
|
|||||
|
2023
Q3 | $3.32M | Sell |
|
|||||
|
2023
Q2 | $4.12M | Buy |
|
|||||
|
2023
Q1 | $4.57M | Sell |
|
|||||
|
2022
Q4 | $6.2M | Sell |
|
|||||
|
2022
Q3 | $5.48M | Buy |
|
|||||
|
2022
Q2 | $6.47M | Buy |
|
|||||
|
2022
Q1 | $6.36M | Sell |
|
|||||
|
2021
Q4 | $7.28M | Sell |
|
|||||
|
2021
Q3 | $5.33M | Sell |
|
|||||
|
2021
Q2 | $5.11M | Sell |
|
|||||
|
2021
Q1 | $4.87M | Sell |
|
|||||
|
2020
Q4 | $25.4M | Sell |
|
|||||
|
2020
Q3 | $26.4M | Sell |
|
|||||
|
2020
Q2 | $23.9M | Sell |
|
|||||
|
2020
Q1 | $96.7M | Sell |
|
|||||
|
2019
Q4 | $138M | Sell |
|
|||||
|
2019
Q3 | $170M | Buy |
|
|||||
|
2019
Q2 | $188M | Buy |
|
|||||
|
2019
Q1 | $138M | Buy |
|
|||||
|
2018
Q4 | $137M | Buy |
|
|||||
|
2018
Q3 | $88.5M | Sell |
|
|||||
|
2018
Q2 | $111M | Buy |
|
|||||
|
2018
Q1 | $100M | Sell |
|
|||||
|
2017
Q4 | $112M | Sell |
|
|||||
|
2017
Q3 | $112M | Sell |
|
|||||
|
2017
Q2 | $118M | Sell |
|
|||||
|
2017
Q1 | $131M | Buy |
|
|||||
|
2016
Q4 | $119M | Sell |
|
|||||
|
2016
Q3 | $137M | Buy |
|
|||||
|
2016
Q2 | $129M | Sell |
|
|||||
|
2016
Q1 | $113M | Buy |
|
|||||
|
2015
Q4 | $121M | Sell |
|
|||||
|
2015
Q3 | $137M | Buy |
|
|||||
|
2015
Q2 | $146M | Buy |
|
|||||
|
2015
Q1 | $144M | Buy |
|
|||||
|
2014
Q4 | $3.06M | Buy |
|
|||||
|
2014
Q3 | $2.64M | Buy |
|
|||||
|
2014
Q2 | $2.57M | Sell |
|
|||||
|
2014
Q1 | $2.85M | Buy |
|
|||||
|
2013
Q4 | $2.7M | Buy |
|
|||||
|
2013
Q3 | $2.53M | Sell |
|
|||||
|
2013
Q2 | $2.62M | Buy |
|